Shi Wenpei, Zhu Haiyan, Yuan Lei, Chen Xiaoyue, Huang Xiaojie, Wang Kai, Li Zhen
Clinical Research Unit, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, China.
Department of Gynecology, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, China.
Front Oncol. 2022 Oct 24;12:955150. doi: 10.3389/fonc.2022.955150. eCollection 2022.
Although vaginal microbiota (VM) may interact with human papillomavirus (HPV) infection and clearance, longitudinal data remain very limited. We aimed to investigate the association between VM at baseline and the clearance of high-risk HPV (HR-HPV) infection within 12 months. Cervical swabs were collected at diagnosis from 85 patients with HR-HPV infection and histologically confirmed cervical lesions, including cervicitis, low-grade squamous intraepithelial lesion and high-grade squamous intraepithelial lesion. Microbiome analysis was performed using 16S rRNA gene sequencing. Among the 73 women included in the analyses, HPV clearance was observed in 58.9% of the patients within 12 months. No significant difference was observed between the HPV-cleared and HPV-uncleared groups regarding age, disease stage, HPV subtype, VM community state types, and VM diversity (α and β). Women with the depletion of enterococcus ASV_62 and enrichment in at baseline were less likely to have HPV clearance at month 12. Further analysis revealed a significant negative association between high abundance of and HPV clearance in patients who received non-operative treatment (OR = 3.94, p = 0.041), but not in those who received operative treatment (OR = 1.86, p = 0.660). Our findings provide new evidence for the potential role of VM in the persistent HR-HPV infections.
虽然阴道微生物群(VM)可能与人乳头瘤病毒(HPV)感染及清除相互作用,但纵向数据仍然非常有限。我们旨在研究基线时的VM与高危型HPV(HR-HPV)感染在12个月内清除之间的关联。在诊断时从85例HR-HPV感染且经组织学确诊有宫颈病变(包括宫颈炎、低级别鳞状上皮内病变和高级别鳞状上皮内病变)的患者中采集宫颈拭子。使用16S rRNA基因测序进行微生物组分析。在纳入分析的73名女性中,58.9%的患者在12个月内观察到HPV清除。在HPV清除组和未清除组之间,在年龄、疾病阶段、HPV亚型、VM群落状态类型和VM多样性(α和β)方面未观察到显著差异。基线时肠球菌ASV_62减少且 富集的女性在第12个月时HPV清除的可能性较小。进一步分析显示,在接受非手术治疗的患者中, 高丰度与HPV清除之间存在显著负相关(OR = 3.94,p = 0.041),但在接受手术治疗的患者中则无此相关性(OR = 1.86,p = 0.660)。我们的研究结果为VM在持续性HR-HPV感染中的潜在作用提供了新证据。